Back to top
more

ABIOMED, Inc. (ABMD)

(Delayed Data from NSDQ)

$271.75 USD

271.75
1,074,902

+6.98 (2.64%)

Updated May 3, 2019 04:00 PM ET

After-Market: $271.72 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[ABMD]

Reports for Purchase

Showing records 181 - 200 ( 286 total )

Industry: Medical - Instruments

Record: 181

10/01/2013

Daily Note

Pages: 8

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 182

09/11/2013

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Instruments

Record: 183

06/17/2013

Company Report

Pages: 10

Price: 24.95

Industry: Medical - Instruments

Record: 184

05/28/2013

Company Report

Pages: 10

Price: 24.95

Industry: Medical - Instruments

Record: 185

03/21/2013

Company Report

Pages: 10

Price: 24.95

Industry: Medical - Instruments

Record: 186

01/15/2013

Company Report

Pages: 9

Price: 24.95

Industry: Medical - Instruments

Record: 187

11/05/2012

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Instruments

Record: 188

08/30/2012

Company Report

Pages: 9

Price: 24.95

Industry: Medical - Instruments

Record: 189

08/14/2012

Company Report

Pages: 4

Dropping Coverage

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 190

07/10/2012

Company Report

Pages: 3

Termination of Coverage

Provider: RODMAN & RENSHAW, CO.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 191

07/10/2012

Company Report

Pages: 9

Price: 24.95

Industry: Medical - Instruments

Record: 192

05/28/2012

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Instruments

Record: 193

05/24/2012

Daily Note

Pages: 3

Analysis on the Feb 24th FDA meeting information

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 194

05/24/2012

Company Report

Pages: 14

Analysis on the Feb 24th FDA meeting information

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 195

05/21/2012

Daily Note

Pages: 3

Medicare subsidiary re-clarifies CPT code usage for Impella...

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 196

05/21/2012

Company Report

Pages: 4

Medicare subsidiary re-clarifies CPT code usage for Impella...

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 197

05/11/2012

Company Report

Pages: 4

Medicare subsidiary clarifies CPT code usage for Impella...

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 198

05/11/2012

Daily Note

Pages: 3

Medicare subsidiary clarifies CPT code usage for Impella...

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 199

05/02/2012

Company Report

Pages: 4

Our thoughts on a potential CPT level reimbursement for Impella....

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 200

05/02/2012

Daily Note

Pages: 3

Our thoughts on a potential CPT level reimbursement for Impella....

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party
// eof